Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06261034 · ClinicalTrials.gov registry record

A Study of Sex Differences in Neurocirculatory Control

A clinical trial of Obstructive Sleep Apnea, sponsored by Mayo Clinic.

Recruiting
Registry status
60
Enrollment target
1
Study location

NCT06261034: Recruiting study of Obstructive Sleep Apnea, sponsored by Mayo Clinic.

NCT06261034 is a study of Obstructive Sleep Apnea that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06261034, a study of Obstructive Sleep Apnea, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate potential sex differences in neurocirculatory control of blood pressure in patients with untreated obstructive sleep apnea (OSA).

Primary Outcome

Measured in millimeters of mercury (mmHg).

Conditions Studied

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-10-29
Est. Completion 2027-03
Mayo Clinic

2,844 total trials

What NCT06261034 shows while recruiting

NCT06261034 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 0 interventions.

NCT06261034 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06261034 about?

NCT06261034 is a clinical study titled "A Study of Sex Differences in Neurocirculatory Control". The purpose of this study is to investigate potential sex differences in neurocirculatory control of blood pressure in patients with untreated obstructive sleep apnea (OSA).

What is the current status of trial NCT06261034?

This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2024-10-29. Estimated completion is 2027-03.

What conditions does trial NCT06261034 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

Who is sponsoring clinical trial NCT06261034?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06261034 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06261034's enrollment target sits among peer trials

60 86th of 155 higher than 60 of 155 other Obstructive Sleep Apnea trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06261034, the US trial registry maintained by the National Library of Medicine. NCT06261034 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.